Carcinoma of unknown primary site treated with Carboplatin + Paclitaxel + bevacizumab + erlotinib and its maintenance chemotherapy - Wikidata - awgldk - TriplyDB

Carcinoma of unknown primary site treated with Carboplatin + Paclitaxel + bevacizumab + erlotinib and its maintenance chemotherapy

Carcinoma of unknown primary site treated with Carboplatin + Paclitaxel + bevacizumab + erlotinib and its maintenance chemotherapy

http://www.wikidata.org/entity/Q34259395

about

Granulocyte colony-stimulating factor-producing carcinoma of unknown primary site.Effective Treatment with Intravitreal Injection of Bevacizumab for Exudative Retinal Detachment Secondary to Choroidal Metastasis of Non-Small Cell Lung Carcinoma

P2860

Q35066926-CA6FB5E7-5B68-43AD-A275-03F6B3AD69D0 Q36176550-B3CFD9C8-1F43-47E5-840F-10F872187977

P2860

Carcinoma of unknown primary site treated with Carboplatin + Paclitaxel + bevacizumab + erlotinib and its maintenance chemotherapy

http://www.wikidata.org/entity/Q34259395

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Carcinoma of unknown primary s ...... d its maintenance chemotherapy

@ast

Carcinoma of unknown primary s ...... d its maintenance chemotherapy

@en

Carcinoma of unknown primary s ...... d its maintenance chemotherapy

@nl

type

label

Carcinoma of unknown primary s ...... d its maintenance chemotherapy

@ast

Carcinoma of unknown primary s ...... d its maintenance chemotherapy

@en

Carcinoma of unknown primary s ...... d its maintenance chemotherapy

@nl

prefLabel

Carcinoma of unknown primary s ...... d its maintenance chemotherapy

@ast

Carcinoma of unknown primary s ...... d its maintenance chemotherapy

@en

Carcinoma of unknown primary s ...... d its maintenance chemotherapy

@nl

P1433

Q34259395-9DD77954-D232-4EE8-9ADD-48AF5F6A4586

P1476

Q34259395-5E2A0F8D-6275-4578-9E9F-A65000373A11

P2093

Q34259395-21EBF124-B716-40B0-9A37-BCB1D6A6DEB3

Q34259395-2F4E0CAA-A17A-4882-9C44-19596354CDBF

Q34259395-31B794AB-A634-46BA-885F-6FA7C9BCA831

Q34259395-34189908-9FB8-4594-B615-9F6932B6F304

Q34259395-41ECB902-3193-4DBB-AB50-FB36465D5575

Q34259395-A200E895-9600-4504-8AF5-E675C1098D56

Q34259395-B047C1F2-1A40-4609-AB47-73C8F8BD8AC0

Q34259395-C5E85E8E-E5E9-4FCB-AEA7-7ACF93034900

Q34259395-DD5C37F3-9F25-4BBC-9DAD-BBDB8D05E081

Q34259395-F419C3DD-C358-44C7-AE78-AD05E1F0E8B3

P2860

Q34259395-0B94AC63-7FFA-44AF-AC73-245CC656D2E5

Q34259395-1246CDCB-67A8-4179-957C-13F638E8DA91

Q34259395-1F037CCD-BF73-4954-B742-DF052DE95AFC

Q34259395-2638DAE7-F1D7-4F2F-974D-75A6E916E701

Q34259395-39E69FFC-A54C-4D32-9870-959BEF5E809E

Q34259395-501F0C6C-887D-4574-AD54-7385156A70EF

Q34259395-5DEAF363-5C20-4700-8414-DE0FA1853347

Q34259395-662170F2-A346-4C57-B187-FD462253B922

Q34259395-6A1F640B-47E3-49BA-95AC-EEB0B72CDFF4

Q34259395-8996EECD-65F3-4995-BD1F-0164CFC48F4A

P304

Q34259395-F5C3457B-F366-4B22-A417-5F71F6814DDB

P31

Q34259395-746CFCB4-66F8-451E-9F4E-E089D1C2BA9B

Q34259395-efc0e860-b965-4417-a731-8ebc4f96d9ac

P356

Q34259395-03839337-B592-4524-A339-05375A11E1F1

P433

Q34259395-15A501AC-EF1B-47E6-A7C5-926A0B93A49F

P478

Q34259395-13C6632C-30A8-4CA8-8FAF-DF487ABF9219

P577

Q34259395-6055310D-4C41-4503-8166-08AC9ACE9183

P5875

Q34259395-2DC10DC8-F693-4639-B58A-6DB8F67875A6

P698

Q34259395-F0C0E20A-0F5C-4B1F-B7DD-E8F73A4AE1AD

P921

Q34259395-8366D7B5-66E0-4DFE-9329-4AF1143FDD9B

P932

Q34259395-4C76121B-6328-4DE3-B2E3-66A009070AC0

P356

P1433

Case reports in oncology

P1476

Carcinoma of unknown primary s ...... d its maintenance chemotherapy

@en

P2093

Hideo Gonda

http://www.w3.org/2001/XMLSchema#string

Hirotoshi Yasui

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Hashimoto

http://www.w3.org/2001/XMLSchema#string

Kazuhide Sato

http://www.w3.org/2001/XMLSchema#string

Matsuyoshi Maeda

http://www.w3.org/2001/XMLSchema#string

Nagashima Yoshihisa

http://www.w3.org/2001/XMLSchema#string

Ryujiro Suzuki

http://www.w3.org/2001/XMLSchema#string

Toshio Kato

http://www.w3.org/2001/XMLSchema#string

Yasutaka Fukui

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Takeyama

http://www.w3.org/2001/XMLSchema#string

P2860

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial.

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial.

Cancer of unknown primary site: 20 questions to be answered.

Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.

P304

583-590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000366268

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266681598

http://www.w3.org/2001/XMLSchema#string

P698

25298764

http://www.w3.org/2001/XMLSchema#string

P921

P932

4178322

http://www.w3.org/2001/XMLSchema#string